Citations (36)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (36)
Raja Mehanna & Joseph Jankovic. 2022. Handbook of Neurotoxicity. Handbook of Neurotoxicity
1095
1143
.
Wolfgang H. Jost & Joerg Müller. 2022. NeuroPsychopharmacotherapy. NeuroPsychopharmacotherapy
2947
2962
.
Kantharuby Tambirajoo, Luciano Furlanetti, Michael Samuel & Keyoumars Ashkan. (2021) Globus Pallidus Internus Deep Brain Stimulation for Dystonic Opisthotonus in Adult-Onset Dystonia: A Personalized Approach. Frontiers in Human Neuroscience 15.
Crossref
Crossref
Shannon Y. Chiu, Matthew R. Burns & Irene A. Malaty. (2021) An Update on Botulinum Toxin in Neurology. Neurologic Clinics 39:1, pages 209-229.
Crossref
Crossref
Raja Mehanna & Joseph Jankovic. 2021. Handbook of Neurotoxicity. Handbook of Neurotoxicity
1
48
.
Shuzhen Chen, Malam Djibo Issa, Chenghong Wang, Liang Feng, Fei Teng, Bing Li, Yougui Pan, Xiaolong Zhang, Yifei Xu, Zhuoyu Zhang, Junhui Su, Hongxing Ma & Lingjing Jin. (2019) [99mTc]MIBI SPECT/CT for Identifying Dystonic Muscles in Patients with Primary Cervical Dystonia. Molecular Imaging and Biology 22:4, pages 1054-1061.
Crossref
Crossref
Seung Ah Lee, Ja-Young Choi & Byung-Mo Oh. (2020) The Effect of Computed Tomography–Guided Botulinum Toxin Injection on Cervical Dystonia, Confirmed by a 9-Month Follow-Up Using Positron Emission Tomography/Computed Tomography. American Journal of Physical Medicine & Rehabilitation 99:1, pages e7-e10.
Crossref
Crossref
S. C. Drexel, M. Klietz, K. Kollewe, L. Paracka, A. Kutschenko, B. Kopp, F. Lange, F. Wegner & D. Dressler. (2019) Caregiver burden and health-related quality of life in idiopathic dystonia patients under botulinum toxin treatment: a cross-sectional study. Journal of Neural Transmission 127:1, pages 61-70.
Crossref
Crossref
Wolfgang H. Jost & Joerg Müller. 2020. NeuroPsychopharmacotherapy. NeuroPsychopharmacotherapy
1
16
.
Won-Jun Lee, Young-Suk Yoon, Jong-Ho Kim, Keun-Jae Lee, Mi-Hye Kim, Ho-Sun Ryu, Su-Bin Han, Byung-Hak Park, Jae-Min Son, Nam-Woo Lee, Jeong-Hun Han, Hye-Jin Seo & Ji-Hoon Kim. (2019) Clinical Study on 1 Case of Cervical Dystonia Treated by Korean Medicine and Transfer Energy Capacitive and Resistive (TECAR) Therapy. Journal of Korean Medicine Rehabilitation 29:4, pages 109-115.
Crossref
Crossref
Veronica Antipova, Carsten Holzmann, Alexander Hawlitschka & Andreas Wree. (2019) Botulinum Neurotoxin-A Injected Intrastriatally into Hemiparkinsonian Rats Improves the Initiation Time for Left and Right Forelimbs in Both Forehand and Backhand Directions. International Journal of Molecular Sciences 20:4, pages 992.
Crossref
Crossref
Isabelle Rieu, Bertrand Degos, Giovanni Castelnovo, Christophe Vial, Elodie Durand, Bruno Pereira, Marion Simonetta-Moreau, Sophie Sangla, Frédérique Fluchère, Dominique Guehl, Pierre Burbaud, Christian Geny, Dominique Gayraud, Fabienne Ory-Magne, Françoise Bouhour, Elisabeth Llinares, Philippe Derost, Ana Marques & Franck Durif. (2018) Incobotulinum toxin A in Parkinson's disease with foot dystonia: A double blind randomized trial. Parkinsonism & Related Disorders 46, pages 9-15.
Crossref
Crossref
Alexander Hawlitschka, Carsten Holzmann, Sarah Witt, Juliane Spiewok, Anne-Marie Neumann, Oliver Schmitt, Andreas Wree & Veronica Antipova. (2017) Intrastriatally injected botulinum neurotoxin-A differently effects cholinergic and dopaminergic fibers in C57BL/6 mice. Brain Research 1676, pages 46-56.
Crossref
Crossref
Dae Chul Sin & Mi Suk Kang. (2016) A Case Report of a Patient with Cervical Dystonia Treated by Korean Medical Treatment Based on Meridian Tendino-Musculature Acupuncture. Korean Journal of Acupuncture 33:4, pages 226-230.
Crossref
Crossref
Oluwadamilola O. Ojo & Hubert H. Fernandez. (2015) Is it time for flexibility in botulinum inter-injection intervals?. Toxicon 107, pages 72-76.
Crossref
Crossref
E. De Bruijn, S.W.R. Nijmeijer, P.A. Forbes, J.H.T.M. Koelman, F.C.T. van der Helm, M.A.J. Tijssen & R. Happee. (2015) Improved identification of dystonic cervical muscles via abnormal muscle activity during isometric contractions. Journal of the Neurological Sciences 354:1-2, pages 10-16.
Crossref
Crossref
S.W.R. Nijmeijer, E. de Bruijn, P.A. Forbes, D.J. Kamphuis, R. Happee, J.H.T.M. Koelman & M.A.J. Tijssen. (2014) EMG coherence and spectral analysis in cervical dystonia: Discriminative tools to identify dystonic muscles?. Journal of the Neurological Sciences 347:1-2, pages 167-173.
Crossref
Crossref
Raja Mehanna & Joseph Jankovic. 2014. Handbook of Neurotoxicity. Handbook of Neurotoxicity
553
590
.
H. A. Jinnah, Alfredo Berardelli, Cynthia Comella, Giovanni DeFazio, Mahlon R. DeLong, Stewart Factor, Wendy R. Galpern, Mark Hallett, Christy L. Ludlow, Joel S. Perlmutter & Ami R. Rosen. (2013) The focal dystonias: Current views and challenges for future research. Movement Disorders 28:7, pages 926-943.
Crossref
Crossref
S.W.R. Nijmeijer, J.H.T.M. Koelman, T.S.M. Standaar, M. Postma & M.A.J. Tijssen. (2013) Cervical dystonia: Improved treatment response to botulinum toxin after referral to a tertiary centre and the use of polymyography. Parkinsonism & Related Disorders 19:5, pages 533-538.
Crossref
Crossref
M. Brown, G. Nicholson, M. C. Ardila, A. Satorius, R. S. Broide, K. Clarke, T. Hunt & J. Francis. (2012) Comparative evaluation of the potency and antigenicity of two distinct BoNT/A-derived formulations. Journal of Neural Transmission 120:2, pages 291-298.
Crossref
Crossref
F. Mark Dunning, Daniel R. Ruge, Timothy M. Piazza, Larry H. Stanker, Füsûn N. Zeytin & Ward C. Tucker. (2012) Detection of Botulinum Neurotoxin Serotype A, B, and F Proteolytic Activity in Complex Matrices with Picomolar to Femtomolar Sensitivity. Applied and Environmental Microbiology 78:21, pages 7687-7697.
Crossref
Crossref
Cathérine C.S. Delnooz & Bart P.C. van de Warrenburg. (2012) Current and future medical treatment in primary dystonia. Therapeutic Advances in Neurological Disorders 5:4, pages 221-240.
Crossref
Crossref
S.W.R. Nijmeijer, J.H.T.M. Koelman, D.J. Kamphuis & M.A.J. Tijssen. (2012) Muscle selection for treatment of cervical dystonia with botulinum toxin – A systematic review. Parkinsonism & Related Disorders 18:6, pages 731-736.
Crossref
Crossref
Daniel Truong. (2012) Botulinum toxins in the treatment of primary focal dystonias. Journal of the Neurological Sciences 316:1-2, pages 9-14.
Crossref
Crossref
Daniel R. Ruge, F. Mark Dunning, Timothy M. Piazza, Brian E. Molles, Michael Adler, Füsûn N. Zeytin & Ward C. Tucker. (2011) Detection of six serotypes of botulinum neurotoxin using fluorogenic reporters. Analytical Biochemistry 411:2, pages 200-209.
Crossref
Crossref
Parthasarathy D. Thirumala, Aalap C. Shah, Tara N. Nikonow, Miguel E. Habeych, Jeffrey R. Balzer, Donald J. Crammond, Lois Burkhart, Yue-Fang Chang, Paul Gardner, Amin B. Kassam & Michael B. Horowitz. (2011) Microvascular Decompression for Hemifacial Spasm: Evaluating Outcome Prognosticators Including the Value of Intraoperative Lateral Spread Response Monitoring and Clinical Characteristics in 293 Patients. Journal of Clinical Neurophysiology 28:1, pages 56-66.
Crossref
Crossref
Andreas Wree, Eilhard Mix, Alexander Hawlitschka, Veronica Antipova, Martin Witt, Oliver Schmitt & Reiner Benecke. (2011) Intrastriatal botulinum toxin abolishes pathologic rotational behaviour and induces axonal varicosities in the 6-OHDA rat model of Parkinson's disease. Neurobiology of Disease 41:2, pages 291-298.
Crossref
Crossref
John W Dunne, Barbara J Singer, Peter L Silbert & Kevin P Singer. (2010) Prolonged vastus lateralis denervation after botulinum toxin type A injection. Movement Disorders 25:3, pages 397-401.
Crossref
Crossref
Andrea Santamato, Maurizio Ranieri, Francesco Panza, Stefano Zoccolella, Vincenza Frisardi, Vincenzo Solfrizzi, Maria Teresa Amoruso, Loredana Amoruso & Pietro Fiore. (2009) Botulinum toxin type A and a rehabilitation program in the treatment of Pisa syndrome in Parkinson’s disease. Journal of Neurology 257:1, pages 139-141.
Crossref
Crossref
S. Mense & Alfonse T. Masi. 2010. Muscle Pain: Understanding the Mechanisms. Muscle Pain: Understanding the Mechanisms
207
249
.
R. Benecke. (2009) Xeomin® in the treatment of cervical dystonia. European Journal of Neurology 16, pages 6-10.
Crossref
Crossref
Joshua P AlpersJanice M Massey. (2009) Cervical dystonia. Future Neurology 4:5, pages 639-647.
Crossref
Crossref
A. Bachhuber, G. Reichel, M. Doberenz, A. Stenner & W. Hermann. (2009) Botulinum-Toxin-BehandlungBotulinum toxin treatment. Der Nervenarzt 80:6, pages 712-716.
Crossref
Crossref
Shin-Young Yim, Il Yung Lee, Myong Chul Park & Jang-Hee Kim. (2009) Differential Diagnosis and Management of Abnormal Posture of the Head and Neck. Journal of the Korean Medical Association 52:7, pages 705.
Crossref
Crossref
Richard M. Kostrzewa & Juan Segura-Aguilar. (2007) Botulinum neurotoxin: Evolution from poison, to research tool - onto medicinal therapeutic and future pharmaceutical panacea. Neurotoxicity Research 12:4, pages 275-290.
Crossref
Crossref